Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.64 USD | -6.05% | -8.97% | -45.90% |
15/05 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
14/05 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.90% | 13Cr | |
+11.18% | 23TCr | |
+15.22% | 20TCr | |
+19.19% | 14TCr | |
+30.89% | 11TCr | |
+1.56% | 6.47TCr | |
+18.48% | 5.44TCr | |
+5.12% | 5.11TCr | |
+10.53% | 4.5TCr | |
+5.98% | 3.74TCr |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- JPMorgan Adjusts Akoya Biosciences' Price Target to $20 from $25, Keeps Overweight Rating